OPEN END TURBO OPTIONSSCHEIN SHORT - ELI LILLY & CO | Market Closed - BOERSE MUENCHEN 19:26:43 05/07/2024 BST | ||
| 6.72 EUR | -17.24% |
|
| Current month | -4.00% | ||
| 1 month | -52.07% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 05/07/24 | 6.72 | -17.24% |
| 04/07/24 | 8.12 | -9.68% |
| 03/07/24 | 8.99 | +21.82% |
| 02/07/24 | 7.38 | +3.22% |
| 01/07/24 | 7.15 | +2.14% |
Real-time BOERSE MUENCHEN
Last update July 05, 2024 at 07:26 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | Goldman Sachs |
| WKN | GQ9FA0 |
| ISIN | DE000GQ9FA02 |
| Date issued | 19/02/2024 |
| Strike | 987.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 18.9 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 24.93 € |
|---|---|
| Lowest since issue | 6.72 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
914.6
USD
Average target price
870.3
USD
Spread / Average Target
-4.84%
- Stock Market
- Certificates
- Certificat
